At the news
? NEUTRALIMPACT 2/10 144 filed Nov 12, 2026 at 16:20 ET
Michael Goldberg, a director of CareDx, filed a Form 144 notice of intent to sell 13,800 shares of common stock, with an approximate market value of $1,120,146 based on the filing date. The shares were acquired upon vesting of restricted stock units from 2020 through July 2026. The sale is a routine insider disposition of vested equity, representing a small fraction of the company's $4.2B market cap.
- Insider: Michael Goldberg, a director of CareDx
- Shares to be sold: 13,800 shares of common stock
- Approximate value: $1,120,146 (based on filing date price)
- Shares acquired via vesting of restricted stock units from 01/02/2020 through 07/02/2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access